Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer

Loss of androgen receptor (AR) signaling dependence occurs in approximately 15%–20% of advanced treatment-resistant prostate cancers, and this may manifest clinically as transformation from a prostate adenocarcinoma histology to a castration-resistant neuroendocrine prostate cancer (CRPC-NE). The di...

詳細記述

保存先:
書誌詳細
出版年:J Clin Invest
主要な著者: Beltran, Himisha, Romanel, Alessandro, Conteduca, Vincenza, Casiraghi, Nicola, Sigouros, Michael, Franceschini, Gian Marco, Orlando, Francesco, Fedrizzi, Tarcisio, Ku, Sheng-Yu, Dann, Emma, Alonso, Alicia, Mosquera, Juan Miguel, Sboner, Andrea, Xiang, Jenny, Elemento, Olivier, Nanus, David M., Tagawa, Scott T., Benelli, Matteo, Demichelis, Francesca
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Clinical Investigation 2020
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7108892/
https://ncbi.nlm.nih.gov/pubmed/32091413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI131041
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料